Levomilnacipran
Back to searchMolecule Structure
Scientific Name
Levomilnacipran
Description of the Drug
Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder (MDD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08918
http://www.drugbank.ca/drugs/DB08918
Brand Name(s)
Fetzima
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Allergan Sales Llc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
| Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1414867 | ||
| DrugBank | DB08918 | ||
| PubChem: Thomson Pharma | 16010452 | ||
| PubChem | 6917779 | ||
| Nikkaji | J259.860D | ||
| BindingDB | 50032379 | ||
| DrugCentral | 4864 | ||
| ChemicalBook | CB13133687 | ||
| Guide to Pharmacology | 7435 | ||
| rxnorm | LEVOMILNACIPRAN | LEVOMILNACIPRAN HYDROCHLORIDE | FETZIMA |
| ChEBI | 136040 | ||
| ZINC | ZINC000000000506 |
